Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
2023-510485-27-00Phase 4Authorised
- Sponsor
- Oslo University Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in kidney transplant comparing Dapagliflozin with Placebo (2 arms). Planned start Jun 2024; status: authorised.
02
Drugs
dapagliflozin
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2023-510485-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510485-27-00.